Antibacterials can reduce the incidence of neonatal early-onset group B streptococcal sepsis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1237, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neonatal group B streptococcal sepsis prevention worthwhile

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Neonatal group B streptococcal sepsis: prevention worthwhile?

By  

Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

NICE issues draft guidelines for early-onset neonatal infections . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Ranitidine elevates risk of neonatal late-onset sepsis

By  

Reactions Weekly, Vol. 1, Iss. 1156, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?

By Binder Helge   Flegel Willy A   Emran Jasmin   Müller Andreas   Cupisti Susanne   Beckmann Matthias W   Eckstein Reinhold   Dittrich Ralf   Ringwald Juergen  

Reproductive BioMedicine Online, Vol. 17, Iss. 2, 2008-08 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite